Driehaus Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
VPM
VCM
Driehaus Capital Management's TWST Position: Q1 2026 in Review
Driehaus Capital Management opened a new position in Twist Bioscience (TWST) in Q1 2026: 584,696 shares worth $27.8M. The stake represents 0.2% of the portfolio and ranks #158 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in TWST as recently as Q2 2024.
Driehaus Capital Management first reported a position in TWST in Q4 2018 and has held it in 13 quarters since. The position peaked at $44.2M in Q4 2020. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.
- Driehaus Capital Management held 584,696 shares of Twist Bioscience worth $27.8M as of Q1 2026.
- Twist Bioscience was a new Driehaus Capital Management position in Q1 2026.
- Twist Bioscience made up 0.2% of Driehaus Capital Management's portfolio in Q1 2026, its #158 holding.
- Driehaus Capital Management first reported a position in Twist Bioscience in Q4 2018 and has held it in 13 quarters since.
- Driehaus Capital Management's Twist Bioscience position peaked at $44.2M in Q4 2020.
- 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.
Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.